|
1
|
Fernandez IE and Eickelberg O: New
cellular and molecular mechanisms of lung injury and fibrosis in
idiopathic pulmonary fibrosis. Lancet. 380:680–688. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alonso SR, Tracey L, Ortiz P, Pérez-Gómez
B, Palacios J, Pollán M, Linares J, Serrano S, Sáez-Castillo AI,
Sánchez L, et al: A high-throughput study in melanoma identifies
epithelial-mesenchymal transition as a major determinant of
metastasis. Cancer Res. 67:3450–3460. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oruqaj G, Karnati S, Vijayan V, Kotarkonda
LK, Boateng E, Zhang W, Ruppert C, Günther A, Shi W and
Baumgart-Vogt E: Compromised peroxisomes in idiopathic pulmonary
fibrosis, a vicious cycle inducing a higher fibrotic response via
TGF-β signaling. Proc Natl Acad Sci USA. 112:pp. 2048–2057. 2015;
View Article : Google Scholar
|
|
4
|
Akhurst RJ and Hata A: Targeting the TGFβ
signalling pathway in disease. Nat Rev Drug Discov. 11:790–811.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Blackwell TS, Tager AM, Borok Z, Moore BB,
Schwartz DZ, Anstom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR,
Bradford W, et al: Future directions in idiopathic pulmonary
fibrosis research. An NHLBI workshop report. Am J Respir Crit Care
Med. 189:pp. 214–222. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iser IC, Pereira MB, Lenz G and Wink MR:
The epithelial-to-mesenchymal transition-like process in
glioblastoma: An updated systematic review and in silico
investigation. Med Res Rev. 37:271–313. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shenoy A and Blelloch RH: Regulation of
microRNA function in somatic stem cell proliferation and
differentiation. Nat Rev Mol Cell Biol. 15:565–576. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holdt LM, Hoffmann S, Sass K, Langenberger
D, Scholz M, Krohn K, Finstermeier K, Stahringer A, Wilfert W,
Beutner F, et al: Alu elements in ANRIL non-coding RNA at
chromosome 9p21 modulate atherogenic cell functions through
trans-regulation of gene networks. PLoS Genet. 9:e10035882013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Payer B, Rosenberg M, Yamaji M, Yabuta Y,
Koyanagi-Aoi M, Hayashi K, Yamanaka S, Saitou M and Lee JT: Tsix
RNA and the germline factor, PRDM14, link X reactivation and stem
cell reprogramming. Mol Cell. 52:805–818. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song R, Walentek P, Sponer N, Klimke A,
Lee JS, Dixon G, Harland R, Wan Y, Lishko P, Lize M, et al:
miR-34/449 miRNAs are required for motile ciliogenesis by
repressing cp110. Nature. 510:115–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nicodemus-Johnson J, Laxman B, Stern RK,
Sudi J, Tierney CN, Norwick L, Hogarth DK, McConville JF, Naureckas
ET, Sperling AI, et al: Maternal asthma and microRNA regulation of
soluble HLA-G in the airway. J Allergy Clin Immunol. 131:1496–1503.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Caruso P, Dempsie Y, Stevens HC, McDonald
RA, Long L, Lu R, White K, Mair KM, McClure JD, Southwood M, et al:
A role for miR-145 in pulmonary arterial hypertension: Evidence
from mouse models and patient samples. Circ Res. 111:290–300. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sayed D and Abdellatif M: MicroRNAs in
development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun Q, Csorba T, Skourti-Stathaki K,
Proudfoot NJ and Dean C: R-loop stabilization represses antisense
transcription at the Arabidopsis FLC locus. Science. 340:619–621.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tollervey JR, Curk T, Rogelj B, Briese M,
Cereda M, Kayikci M, König J, Hortobágyi T, Nishimura AL, Zupunski
V, et al: Characterizing the RNA targets and position-dependent
splicing regulation by TDP-43. Nat Neurosci. 14:452–458. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gontan C, Achame EM, Demmers J, Barakat
TS, Rentmeester E, van IJcken W, Grootegoed JA and Gribnau J: RNF12
initiates X-chromosome inactivation by targeting REX1 for
degradation. Nature. 485:386–390. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kino T, Hurt DE, Ichijo T, Nader N and
Chrousos GP: Noncoding RNA gas5 is a growth arrest- and
starvation-associated repressor of the glucocorticoid receptor. Sci
Signal. 3:ra82010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Li D, Zhang W, Guo M and Zhan Q:
Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6
mRNA decay. EMBO J. 31:4415–4427. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hung T, Wang Y, Lin MF, Koegel AK, Kotake
Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al:
Extensive and coordinated transcription of noncoding RNAs within
cell-cycle promoters. Nat Genet. 43:621–629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee S, Kopp F, Chang TC, Sataluri A, Chen
B, Sivakumar S, Yu H, Xie Y and Mendell JT: Noncoding RNA NORAD
regulates genomic stability by sequestering PUMILIO proteins. Cell.
164:69–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao G, Zhang J, Wang M, Song X, Liu W, Mao
C and Lv C: Differential expression of long non-coding RNAs in
bleomycin-induced lung fibrosis. Int J Mol Med. 32:355–364.
2013.PubMed/NCBI
|
|
23
|
Song X, Cao G, Jing L, Lin S, Wang X,
Zhang J, Wang M, Liu W and Lv C: Analysing the relationship between
lncRNA and protein-coding gene and the role of lncRNA as ceRNA in
pulmonary fibrosis. J Cell Mol Med. 18:991–1003. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Foster KA, Oster CG, Mayer MM, Avery ML
and Audus KL: Characterization of the A549 cell line as a type II
pulmonary epithelial cell model for drug metabolism. Exp Cell Res.
243:359–366. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vockley CM, D'Ippolito AM, McDowell IC,
Majoros WH, Safi A, Song L, Crawford GE and Reddy TE: Direct GR
binding sites potentiate clusters of TF binding across the human
genome. Cell. 166:1269–1281. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pardo A, Gibson K, Cisneros J, Richards
TJ, Yang Y, Becerril C, Yousem S, Herrera I, Ruiz V, Selman M and
Kaminski N: Up-regulation and profibrotic role of osteopontin in
human idiopathic pulmonary fibrosis. PLoS Med. 2:e2512005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roberts JR, Perkins GD, Fujisawa T,
Pettigrew KA, Gao F, Ahmed A and Thickett DR: Vascular endothelial
growth factor promotes physical wound repair and is anti-apoptotic
in primary distal lung epithelial and A549 cells. Crit Care Med.
35:2164–2170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mao C, Zhang J, Lin S, Jing L, Xiang J,
Wang M, Wang B, Xu P, Liu W, Song X and Lv C: miR-30a inhibits
AECs-II apoptosis by blocking mitochondrial fission dependent on
Drp-1. J Cell Mol Med. 18:2404–2416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang S, Liu H, Liu Y, Zhang J, Li H, Liu
W, Cao G, Xv P, Zhang J, Lv C and Song X: miR-30a as potential
therapeutics by targeting TET1 through regulation of Drp-1 promoter
hydroxymethylation in idiopathic pulmonary fibrosis. Int J Mol Sci.
18:pii: E6332017. View Article : Google Scholar
|
|
30
|
Zhang YL: The value of disease. Guangxi
Normal University Press; Guilin: 2014
|
|
31
|
Vancheri C, Failla M, Crimi N and Raghu G:
Idiopathic pulmonary fibrosis: A disease with similarities and
links to cancer biology. Eur Respir J. 35:496–504. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vancheri C: Idiopathic pulmonary fibrosis:
An altered fibroblast proliferation linked to cancer biology. Proc
Am Thorac Soc. 9:pp. 153–157. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang C, Yang Y and Liu L: Interaction of
long noncoding RNAs and microRNAs in the pathogenesis of idiopathic
pulmonary fibrosis. Physiol Genomics. 47:463–469. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun H, Chen J, Qian W, Kang J, Wang J,
Jiang L, Qiao L, Chen W and Zhang J: Integrated long non-coding RNA
analyses identify novel regulators of epithelial-mesenchymal
transition in the mouse model of pulmonary fibrosis. J Cell Mol
Med. 20:1234–1246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yue B, Cai D, Liu C, Fang C and Yan D:
Linc00152 functions as a competing endogenous RNA to confer
oxaliplatin resistance and holds prognostic values in colon cancer.
Mol Ther. 24:2064–2077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xing Z, Lin A, Li C, Liang K, Wang S, Liu
Y, Park P, Qin L, Wei Y, Hawke D, et al: lncRNA directs cooperative
epigenetic regulation downstream of chemokine signals. Cell.
159:1110–1125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang J, Xv P, Wang Y, Wang M, Li H, Lin
S, Mao C, Wang B, Song X and Lv C: Astaxanthin prevents pulmonary
fibrosis by promoting myofibroblast apoptosis dependent on
Drp1-mediated mitochondrial fission. J Cell Mol Med. 19:2215–2231.
2015.PubMed/NCBI
|
|
38
|
Wang M, Zhang J, Song X, Liu W, Zhang L,
Wang X and Lv C: Astaxanthin ameliorates lung fibrosis both in vivo
and in vitro through preventing transdifferentiation, inhibiting
proliferation, and promoting apoptosis of activated cells. Food
Chem Toxicol. 56:450–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Alipio ZA, Jones N, Liao W, Yang J,
Kulkarni S, Kumar K Sree, Hauer-Jensen M, Ward DC, Ma Y and Fink
LM: Epithelial to mesenchymal transition (EMT) induced by bleomycin
or TFG(b1)/EGF in murine induced pluripotent stem cell-derived
alveolar Type II-like cells. Differentiation. 82:89–98. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cho MS, Rupaimoole R, Choi HJ, Noh K, Chen
J, Hu Q, Sood AK and Afshar-Kharghan V: Complement component 3 is
regulated by TWIST1 and mediates epithelial-mesenchymal transition.
J Immunol. 196:1412–1418. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Uttamsingh S, Bao X, Nguyen KT, Bhanot M,
Gong J, Chan JL, Liu F, Chu TT and Wang LH: Synergistic effect
between EGF and TGF-beta1 in inducing oncogenic properties of
intestinal epithelial cells. Oncogene. 27:2626–2634. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kao CJ, Martiniez A, Shi XB, Yang J, Evans
CP, Dobi A, White RW deVere and Kung HJ: miR-30 as a tumor
suppressor connects EGF/Src signal to ERG and EMT. Oncogene.
33:2495–2503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Braun J, Hoang-Vu C, Dralle H and
Hüttelmaier S: Downregulation of microRNAs directs the EMT and
invasive potential of anaplastic thyroid carcinomas. Oncogene.
29:4237–4244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Selman M, Pardo A, Barrera L, Estrada A,
Watson SR, Wilson K, Aziz N, Kaminski N and Zlotnik A: Gene
expression profiles distinguish idiopathic pulmonary fibrosis from
hypersensitivity pneumonitis. Am J Respir Crit Care Med.
173:188–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nakerakanti SS, Kapanadze B, Yamasaki M,
Markiewicz M and Trojanowska M: Fli1 and Ets1 have distinct roles
in connective tissue growth factor/CCN2 gene regulation and
induction of the profibrotic gene program. J Biol Chem.
281:25259–25269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Noé G, Bellesoeur A, Thomas-Schoemann A,
Rangarajan S, Naji F, Puszkiel A, Huillard O, Saidu N, Golmard L,
Alexandre J, et al: Clinical and kinomic analysis identifies
peripheral blood mononuclear cells as a potential pharmacodynamic
biomarker in metastatic renal cell carcinoma patients treated with
sunitinib. Oncotarget. 7:67507–67520. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fernandez IE, Greiffo FR, Frankenberger M,
Bandres J, Heinzelmann K, Neurohr C, Hatz R, Hartl D, Behr J and
Eickelberg O: Peripheral blood myeloid-derived suppressor cells
reflect disease status in idiopathic pulmonary fibrosis. Eur Respir
J. 48:1171–1183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Roderburg C and Luedde T: Circulating
microRNAs as markers of liver inflammation, fibrosis and cancer. J
Hepatol. 61:1434–1437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
du Bois RM: Strategies for treating
idiopathic pulmonary fibrosis. Nat Rev Drug Discov. 9:129–140.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kumar MS, Armenteros-Monterroso E, East P,
Chakravorty P, Matthews N, Winslow MM and Downward J: HMGA2
functions as a competing endogenous RNA to promote lung cancer
progression. Nature. 505:212–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Karreth FA, Reschke M, Ruocco A, Ng C,
Chapuy B, Léopold V, Sjoberg M, Keane TM, Verma A, Ala U, et al:
The BRAF pseudogene functions as a competitive endogenous RNA and
induces lymphoma in vivo. Cell. 161:319–332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S,
Jiang Z, Xu J, Liu Q and Cao X: The STAT3-binding long noncoding
RNA lnc-DC controls human dendritic cell differentiation. Science.
344:310–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li X, Su Y, Sun B, Ji W, Peng Z, Xu Y, Wu
M and Su C: An artificially-designed interfering lncRNA expressed
by oncolytic adenovirus competitively consumes oncomiRs to exert
antitumor efficacy in hepatocellular carcinoma. Mol Cancer Ther.
15:1436–1451. 2016. View Article : Google Scholar : PubMed/NCBI
|
